Synlogic (SYBX) Initiates Phase 3 Study of SYNB1934 Jun 5, 2023 06:45AM
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria Jun 5, 2023 06:45AM
Synlogic (SYBX) Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update Nov 30, 2022 04:20PM
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business Update Nov 30, 2022 04:15PM